retatrutide parkinson clinical trial nct Retatrutide Dosing: Early Trial Insights on How It Might Work retatrutide parkinson's clinical trial Reta – Triple hormone receptor agonist retatrutide

Jan 20, 2026 9 min read READ MORE Fitness GLP-1 and Strength Training: The Key to Lasting Weight Loss Using a GLP-1 medication

TRIUMPH-4 is the first pivotal trial to confirm that the weight-loss signal seen in Phase 2 scales with longer exposure and higher doses, and it adds several new secondary findings that reshape how researchers think about 9 mg and 12 mg as working doses

Our specialists can help you determine if a dose is still safe to take or if it is time to start a new vial

Consumers using or planning to use GLP-1 medications can be expected to make definite changes in the amount of food they buy and eat, what they eat and how often they eat, PwC said in a new report, The Business of Losing Weight: How Weight-Loss Drugs are Disrupting Consumer Industries, released Jan

Medical weight loss works best when it is properly supervised

The long-term safety data for retatrutide is currently limited, but a full list of side effects will be made available once the medication has completed testing and been approved